Clinique Partners with Icahn School of Medicine at Mount Sinai to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

Rhea-AI Summary

Clinique and Icahn School of Medicine at Mount Sinai have announced a partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center. The center aims to conduct research in dermatology, focusing on skin aging, allergies, and inflammatory skin conditions. The partnership will develop treatments for skin conditions, including eczema and contact dermatitis, and work towards slowing the visible signs of aging in patients with these conditions. The research will also inform Clinique's future product innovation to offer solutions for people with allergic or sensitive skin. Clinique has committed $5 million over seven years for the center's advancement and evolution of allergy science.

Dermatologist

A partnership between Clinique and the Icahn School of Medicine at Mount Sinai to establish a dermatology research center is a significant development in the field of skin health. The focus on understanding the biological mechanisms of skin aging and allergic skin conditions like eczema and contact dermatitis has the potential to lead to groundbreaking treatments. From a dermatological perspective, the commitment to bridge basic science with clinical application is commendable, as it promises to accelerate the translation of research findings into tangible patient benefits. The center's research into 'inflammaging'—the chronic inflammation that contributes to aging—could revolutionize our approach to both skin diseases and age-related skin deterioration.

Pharmaceutical Research Analyst

The strategic collaboration between a leading skincare brand and a renowned medical institution is poised to catalyze innovation in topical and systemic treatments for allergic skin conditions. The investment of $5 million over seven years underscores the potential for high-impact research and development in dermatology. This partnership is likely to result in a robust pipeline of new therapeutics that could be significant for the pharmaceutical industry. The emphasis on comprehensive molecular maps of atopic dermatitis is particularly noteworthy, as it suggests a personalized medicine approach that could lead to more effective, targeted treatments for patients. This could have substantial implications for the market, considering the increasing demand for dermatological solutions.

Market Research Analyst

From a market perspective, the Mount Sinai-Clinique partnership represents a strategic move by Clinique to align itself with cutting-edge scientific research, potentially enhancing its brand reputation and product portfolio. As consumer awareness and demand for scientifically-backed, allergy-tested skincare products grow, this alliance could position Clinique favorably in the competitive beauty and skincare market. The focus on diversity in research participants—spanning all ages, genders, races and ethnicities—also aligns with current market trends towards inclusivity and personalized skincare solutions. The insights gained from this research are likely to influence future product development, enabling Clinique to cater to a broader consumer base with specific skin health needs.

New Research Center Aims to Deliver Breakthrough Advancements in Dermatology and Discover Solutions for Healthy and Allergic Skin

NEW YORK--(BUSINESS WIRE)-- Clinique and Icahn School of Medicine at Mount Sinai today announced a philanthropic partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center. The Center will develop forward-thinking research in dermatology, exploring the biological underpinnings of how skin ages, skin allergies and inflammatory or eczematous skin conditions, including eczema (or atopic dermatitis) and contact dermatitis. Rooted in a shared mission to conduct dermatological research that improves patients’ lives, the partnership will focus on applicable scientific discovery and leading-edge innovation to modernize allergy science in order to identify innovative solutions for these skin conditions.

Research conducted under the Mount Sinai-Clinique Healthy Skin Dermatology Center aims to uncover scientific findings to accelerate the creation of new topical and systemic treatments that help alleviate allergic skin conditions. The priority is to bridge basic science with practical application in the clinic to improve people’s lives through healthy skin. By investigating healthy skin, along with the skin of those with atopic dermatitis and other allergic skin disorders, the researchers may learn how to significantly slow the visible signs of aging in all people as well as in patients with eczema, who show signs of premature or accelerated aging. Insights from this research aim to spur advances in the field of dermatology and skin health. Additionally, they will inform and inspire Clinique in future product innovation to offer further solutions for people with allergic or sensitive skin.

“As a brand that has offered dermatologist guided solutions and allergy tested solutions since its inception, Clinique is proud to partner with the renowned institution of Icahn Mount Sinai and its team of physician-scientists, led by a world-renowned expert in allergic and inflammatory skin diseases, Dr. Emma Guttman. We are inspired by the team’s dedication to the research and future discoveries of allergic skin and its life impact, including aging. We are energized by our mutual commitment and steadfast belief that great skin can be created and maintained for all. I am confident that this first-of-its-kind partnership will enable groundbreaking research by leading physician-scientists dedicated to advancing allergy science,” Michelle Freyre, President, Global Brands, Clinique.

Dr. Emma Guttman, MD, PhD, Waldman Professor and System Chair, Department of Dermatology at the Icahn School of Medicine, a trailblazer in dermatologic science, has dedicated her career to bridging science with practice intended to improve patients’ lives. Her work has led to novel therapeutic targets for patients suffering from inflammatory skin conditions. Drawing inspiration from her personal and family history of eczema and other allergic conditions, Dr. Guttman has made it her mission to alleviate sensitive skin.

“Years of chronic inflamed skin plays a role in premature aging. Extensive research has helped us understand the molecular map of skin conditions associated with allergy such as eczema and contact dermatitis, and we’re now at a pivotal point in addressing these conditions and more. With Clinique’s support, we will continue to actively explore targeted approaches to reversing eczematous and allergic skin conditions with the goal of creating and sustaining healthy skin. In turn, we want to use this understanding to address and prevent the process of age-related inflammation or ‘inflammaging’ in the first place,” says Dr. Guttman, who also directs the Center of Excellence in Eczema at Mount Sinai and the Laboratory of Inflammatory Skin Diseases at Icahn Mount Sinai.

The laboratory of Inflammatory Skin Diseases at Icahn Mount Sinai has a major focus on atopic dermatitis, contact dermatitis, alopecia areata, and other inflammatory skin diseases. It has made paradigm-shifting discoveries on the immunologic basis of atopic dermatitis, opening the door to new therapeutics. Dr. Guttman’s lab developed the only comprehensive molecular maps of atopic dermatitis, defining skin differentiation and immune-circuits characterizing this disease across phenotypes and ages. This work on atopic dermatitis/eczema has contributed directly to many of the recently developed treatments for this disease, earning Dr. Guttman and her lab a unique place as being a top leader in dermatology and immunology worldwide.

Clinique has a long-standing history of partnering with dermatologists, including its Founding Dermatologist, Norman Orentreich, MD, and incorporating patients’ insights in its innovation since 1968. His children, Catherine Orentreich, MD, and David Orentreich, MD, the brand’s Guiding Dermatologists, continue their father’s legacy for Clinique. Dr. David Orentreich is Assistant Clinical Professor of Dermatology at Icahn Mount Sinai, and he and Dr. Catherine Orentreich are members of the Mount Sinai Dermatology Advisory Board.

In this meaningful mission, Clinique has made a philanthropic commitment of $5 million over seven years for the advancement and evolution of allergy science through the partnership and founding of the Mount Sinai-Clinique Healthy Skin Dermatology Center. The funds will be used to recruit the best and brightest physicians and scientists, and provide resources for the most advanced equipment, clinical and laboratory space, and key support staff. The studies conducted by the Mount Sinai-Clinique Healthy Skin Dermatology Center will include all ages, genders, races and ethnicities, and will also investigate the effects of factors such as diet, exercise, and stress on the skin of healthy people. Mount Sinai predicts that with Clinique’s support, critical breakthroughs will be fast-tracked, from the earliest stages of the multiyear partnership.

About Mount Sinai Health System:
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, more than 400 outpatient practices, more than 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time—discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it. Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,400 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. Hospitals within the System are consistently ranked by Newsweek’s® “The World’s Best Smart Hospitals, Best in State Hospitals, World Best Hospitals and Best Specialty Hospitals” and by U.S. News & World Report's® “Best Hospitals” and “Best Children’s Hospitals.” The Mount Sinai Hospital is on the U.S. News & World Report® “Best Hospitals” Honor Roll for 2023-2024.

About Clinique:
In 1968, a beauty editor asked a leading New York City dermatologist, “Can great skin be created?” The answer: yes. And with that yes, Clinique was born. Today Clinique is the #1 Dermatologist Brand in Skincare in the US* and #1 Dermatologist Brand in Makeup in the US**, offering its dermatologist guided, allergy tested solutions for remarkable skin results. The brand is sold in 107 markets worldwide. Clinique’s clinical solutions are informed by years of research, working with dermatologists, scientists, and ophthalmologists. All Clinique formulas are designed to deliver powerful efficacy with rigorous safety —clinically proven, allergy tested, and 100% fragrance free.

*Source: Circana, U.S. Prestige Beauty Total Measured Market, Skincare Unit Sales, Derm Brand Attribute, 12 Months Ending December 2023
**Source: Circana, U.S. Prestige Beauty Total Measured Market, Makeup Unit Sales, Derm Brand Attribute, 12 Months Ending December 2023

Derm Brand is defined as a brand that was founded or developed by a dermatologist and/or is dermatologist recommended.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240202954316/en/

Icahn Mount Sinai: Laura Ruocco-Duran: Laura.Ruocco-Duran@mountsinai.org

Clinique: Dorota Sekulska: DSekulsk@clinique.com

Source: Clinique

FAQ

What is the partnership between Clinique and Icahn School of Medicine at Mount Sinai about?

The partnership aims to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center to conduct research in dermatology, focusing on skin aging, allergies, and inflammatory skin conditions.

What skin conditions will the research focus on?

The research will focus on skin conditions such as eczema (atopic dermatitis) and contact dermatitis.

How will the research inform Clinique's future product innovation?

The research will inform Clinique's future product innovation to offer further solutions for people with allergic or sensitive skin.

How much has Clinique committed to the advancement and evolution of allergy science through the partnership?

Clinique has made a philanthropic commitment of $5 million over seven years for the advancement and evolution of allergy science through the partnership and founding of the Mount Sinai-Clinique Healthy Skin Dermatology Center.